Oncotarget

Meta-Analysis:

Association of COL1A1 rs1800012 polymorphism with musculoskeletal degenerative diseases: a meta-analysis

Binlong Zhong, Donghua Huang, Kaige Ma, Xiangyu Deng, Deyao Shi, Fashuai Wu and Zengwu Shao _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:75488-75499. https://doi.org/10.18632/oncotarget.20797

Metrics: PDF 825 views  |   HTML 1873 views  |   ?  


Abstract

Binlong Zhong1,*, Donghua Huang1,*, Kaige Ma1, Xiangyu Deng1, Deyao Shi1, Fashuai Wu1 and Zengwu Shao1

1Department of Orthopaedic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People’s Republic of China

*These authors contributed equally to this study and share first authorship

Correspondence to:

Zengwu Shao, email: szwpro@163.com

Keywords: COL1A1 polymorphism, rs1800012, musculoskeletal degenerative diseases, osteoarthritis, intervertebral disc degeneration

Received: June 27, 2017     Accepted: August 23, 2017     Published: September 08, 2017

ABSTRACT

It has been reported that the single nucleotide polymorphism (SNP) rs1800012 in COL1A1 gene might be linked to the susceptibility of musculoskeletal degenerative diseases, such as osteoarthritis (OA) and intervertebral disc degeneration (IVDD). However, the data from different studies is contradictory. Here we aimed to comprehensively summarize and clarify the relationship between the SNP and musculoskeletal degenerative diseases. Seven eligible studies including 1339 cases and 5406 controls were screened out from PubMed, Web Of Science and Cochrane library databases. Significant association was identified in sub group analysis of IVDD in homozygote model (GG versus TT: OR = 0.33, 95% CI 0.14–0.78, P = 0.012), heterozygote model (GT versus TT: OR = 0.29, 95% CI 0.11–0.72, P = 0.008) and dominant model (GG/GT versus TT: OR = 0.31, 95% CI 0.13–0.74, P = 0.008). Additionally, significant relationship was also found in sub group analysis of severe degree of IVDD in homozygote model (GG versus TT: OR = 0.37, 95% CI 0.15–0.91, P = 0.031), heterozygote model (GT versus TT: OR = 0.33, 95% CI 0.13–0.87, P = 0.024) and dominant model (GG/GT versus TT: OR = 0.36, 95% CI 0.14–0.88, P = 0.025). Although no significance was observed, there is a trend that the more G allele at COL1A1 rs1800012 site, the less possibility of IVDD and severe IVDD would happen. Our results indicate that COL1A1 rs1800012 polymorphism associates with the susceptibility of IVDD. However, this polymorphism may not be associated with OA risk.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 20797